Home » Stocks » CVET

Covetrus, Inc. (CVET)

Stock Price: $36.88 USD -1.54 (-4.01%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 5.01B
Revenue (ttm) 4.23B
Net Income (ttm) -104.00M
Shares Out 116.00M
EPS (ttm) -0.52
PE Ratio n/a
Forward PE 34.36
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $36.88
Previous Close $38.42
Change ($) -1.54
Change (%) -4.01%
Day's Open 38.08
Day's Range 36.01 - 38.27
Day's Volume 1,018,611
52-Week Range 5.64 - 38.42

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Seeking Alpha - 4 days ago

Covetrus, Inc. presents as a value proposition on a backdrop of incremental growth and successful acquisition integrations. Success in the high margin prescription management segment acts as a...

Business Wire - 1 week ago

PORTLAND, Maine--(BUSINESS WIRE)-- #animalhealth--Animal-health technology and services company, Covetrus, to participate in the 39th Annual J.P. Morgan Healthcare Conference.

Zacks Investment Research - 2 weeks ago

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 3 weeks ago

Covetrus (CVET) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

InvestorPlace - 1 month ago

Finding cheap stocks isn't just about price -- it's about finding great companies that are trading at a discout to their actual worth. The post 5 Cheap Stocks With Great-Performing Companies a...

Other stocks mentioned: AB, ATCO, CODI, GTN
Business Wire - 1 month ago

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus completes separation from former parent company ahead of schedule enabling the Company to deliver greater coordination of its businesses.

InvestorPlace - 1 month ago

More households own pets than have children, and they'll pay to keep their furry friends happy. Here are 6 big pet stocks.

Other stocks mentioned: FDS, HSIC, MRK, NSRGY, ZTS
Zacks Investment Research - 1 month ago

Covetrus (CVET) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Investment Research - 1 month ago

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

Seeking Alpha - 2 months ago

Covetrus' (CVET) CEO Ben Wolin on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Covetrus (CVET) delivered earnings and revenue surprises of 43.75% and 8.17%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 2 months ago

Shares of Covetrus (NASDAQ:CVET) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 52.94% year over year to $0.26, which bea...

GlobeNewsWire - 2 months ago

PORTLAND, Maine, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Covetrus, Inc. (Nasdaq: CVET), a global leader in animal-health technology and services, today announced financial results for the third quar...

Zacks Investment Research - 2 months ago

CVET vs. CRWD: Which Stock Is the Better Value Option?

Other stocks mentioned: CRWD
Zacks Investment Research - 2 months ago

Covetrus (CVET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 2 months ago

PORTLAND, Maine, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release third quarter 2020 re...

Zacks Investment Research - 2 months ago

Covetrus (CVET) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Investment Research - 2 months ago

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 2 months ago

CVET vs. CRWD: Which Stock Is the Better Value Option?

Other stocks mentioned: CRWD
InvestorPlace - 3 months ago

Chewy, Zoetis and FreshPet are just a couple of the names on our list of pet stocks to buy. Let's look at this growing industry more closely.

Other stocks mentioned: CHWY, FRPT, IDXX, PETS, SJM, ZTS
Business Wire - 3 months ago

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus made a strategic investment in VSG, the leading provider of peer-to-peer learning experiences for veterinary practice leaders.

Forbes - 3 months ago

Covetrus, Inc. (NASDAQ : CVET; $22.98; Market Capitalization: $2.6 billion) is on a path of fast-tracked recovery as the company has managed to successfully reboot its operations in the U. S.,...

Business Wire - 3 months ago

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus announced the agenda and speaker lineup for its annual VetSummit conference that is to take place October 16-18.

InvestorPlace - 4 months ago

Despite the economic challenges of the pandemic, Americans are spoiling their pets. Profit from that hot market with these top growth stocks.

Other stocks mentioned: AMZN, MRK, NSRGY, ZTS
Business Wire - 4 months ago

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus, a global leader in animal-health technology & services, announces appointment of Jamey Seely as general counsel effective Sept. 1, 2020.

Business Wire - 4 months ago

PHOENIX--(BUSINESS WIRE)--Covetrus donated 6,000 bottles of hand sanitizer to help protect Phoenix communities and Arizona medical personnel from coronavirus.

Zacks Investment Research - 4 months ago

CVET vs. SOGO: Which Stock Is the Better Value Option?

Other stocks mentioned: SOGO
Zacks Investment Research - 5 months ago

Does Covetrus (CVET) have what it takes to be a top stock pick for momentum investors? Let's find out.

Seeking Alpha - 5 months ago

Covetrus Inc. (CVET) CEO Ben Wolin on Q2 2020 Results - Earnings Call Transcript

Benzinga - 5 months ago

Shares of Covetrus (NASDAQ:CVET) were flat in after-market trading after the company reported Q2 results.

Zacks Investment Research - 5 months ago

Covetrus (CVET) delivered earnings and revenue surprises of 137.50% and 13.89%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 5 months ago

PORTLAND, Maine, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Covetrus (Nasdaq: CVET), a global leader in animal-health technology and services, today announced financial results for the second quarter...

Zacks Investment Research - 5 months ago

Covetrus (CVET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 5 months ago

PORTLAND, Maine, July 28, 2020 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 20...

Business Wire - 6 months ago

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus announces promotion of Ditte Marstrand Wulf to global chief human resources officer.

GlobeNewsWire - 6 months ago

PORTLAND, Maine, June 25, 2020 (GLOBE NEWSWIRE) -- Covetrus ™ (NASDAQ: CVET), a global leader in animal-health technology and services, announced today its board of directors has declared a...

The Motley Fool - 6 months ago

With these three animal-health stocks, your portfolio will be stronger than ever.

Other stocks mentioned: ELAN, ZTS
InvestorPlace - 6 months ago

The ProShares Pet Care ETF is the only ETF dedicated to pet stocks

Other stocks mentioned: CHWY, FRPT, GIS, IDXX, TRUP, ZTS
Zacks Investment Research - 7 months ago

As of late, it has definitely been a great time to be an investor in Covetrus.

Seeking Alpha - 8 months ago

Covetrus Inc. (CVET) CEO Ben Wolin on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Covetrus (CVET) delivered earnings and revenue surprises of -5.56% and -0.27%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 8 months ago

Covetrus (CVET) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 8 months ago

Covetrus (CVET) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 8 months ago

Covetrus (CVET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Benzinga - 9 months ago

Benzinga Pro's Stocks To Watch For Tuesday Covetrus (CVET) - The company is engaged in the sale of animal-health consumable products, pet-care equipment and branded and generic pharmaceuticals...

Seeking Alpha - 9 months ago

CVET: 160% Return In 3-5 Years

Seeking Alpha - 10 months ago

Covetrus Inc. (CVET) CEO Ben Wolin on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

CVET vs. ARCE: Which Stock Is the Better Value Option?

Other stocks mentioned: ARCE
Zacks Investment Research - 1 year ago

Here we pick five Internet-based stocks that are well-poised to grow based on strong industry fundamentals including data explosion and rapid 5G deployment.

Other stocks mentioned: EGOV, MOMO, VIPS, ZUO
Zacks Investment Research - 1 year ago

CVET vs. ARCE: Which Stock Is the Better Value Option?

Other stocks mentioned: ARCE

About CVET

Covetrus, together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, and vitamins and supplements to wholesale and retail customers. The company also offers value-added practice solutions that include financ... [Read more...]

Industry
Health Information Services
CEO
Benjamin Wolin
Employees
5,100
Stock Exchange
NASDAQ
Ticker Symbol
CVET
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Covetrus stock is "Buy." The 12-month stock price forecast is 27.00, which is a decrease of -26.79% from the latest price.

Price Target
$27.00
(-26.79% downside)
Analyst Consensus: Buy